Does J1576 require prior authorization?

Yes, J1576 requires prior authorization (high confidence). At least one active policy explicitly requires prior authorization.

What is the Medicare reimbursement rate for J1576?

Medicare facility rate: N/A. Non-facility rate: N/A. Work RVU: 0.00.

Backwork Sign up free

`J1576`, Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g.,

HCPCS/CPT

Prior Authorization

Prior Auth Required

At least one active policy explicitly requires prior authorization (high confidence)

Medicare Pricing

Work RVU

0.00

Facility

N/A

Non-Facility

N/A

Documentation Required

Claims missing required NOC narrative information or with incorrect unit reporting will be rejected as unprocessable and may show remark code M123.
All documentation must be maintained in the patient's medical record, be legible, include complete patient identification and dates of service, and be produced upon contractor request.
Medical records must include the legible signature of the physician or non-physician practitioner responsible for the care.
The submitted medical record must support the ICD-10-CM code(s), the CPT/HCPCS code(s) billed, and the medical necessity of services as stated in the applicable NCD and LCD.
Records should include relevant diagnostic laboratory studies, prior history of bleeding or infection, disease progression, prior medical/surgical therapies, vaccination response, and any other information essential to establish that the patient meets NCD/LCD coverage indications.
Accurate patient weight in kilograms must be documented prior to infusion because immune globulin dosing is mg/kg based.

Key Coverage Criteria

Billing and coding guidance in this article applies when immune globulin use meets the reasonable and necessary coverage criteria established in LCD L35093.
Coverage requires documentation that the immune globulin therapy is reasonable and necessary in accordance with LCD L34007 and applicable NCDs.
Off-label IVIG use may be billed when supported by the applicable Local Coverage Determination (LCD) and by documentation of medical necessity; off-label is defined as not in Medicare-approved compendia or the FDA label.
IVIG may be used in bone marrow/stem cell transplantation when the recipient was CMV seropositive before transplantation, or after allogeneic transplantation for hematologic neoplasm when both donor and recipient were CMV seronegative.
IVIG may be used in solid organ transplantation when the donor was CMV seropositive and the recipient was CMV seronegative prior to transplantation.
IVIG may be used for recurrent severe infections when there is documented severe or absent IgG subclass deficiency or clinically significant functional humoral immunity deficiency (failure to produce specific antibodies) with a history of recurrent infections.

20 Active Policies

NGS-J6-L39314, Off-Label Use of Intravenous Immune Globulin (IVIG)

A59105, Billing and Coding: Off-Label Use of Intravenous Immune Globulin (IVIG)

FIRST_COAST-L34007, Immune Globulin

A57778, Billing and Coding: Immune Globulin

NORIDIAN-JE-L34314, Immune Globulin Intravenous (IVIg)

NORIDIAN-JF-L34314, Immune Globulin Intravenous (IVIg)

NOVITAS-JH-L35093, Immune Globulin

PALMETTO-JJ-L34580, Intravenous Immunoglobulin (IVIG)

NGS-JK-L39314, Off-Label Use of Intravenous Immune Globulin (IVIG)

A56786, Billing and Coding: Immune Globulin

NOVITAS-JL-L35093, Immune Globulin

PALMETTO-JM-L34580, Intravenous Immunoglobulin(IVIG)

MODA-INTRAVENOUSIMMUNEGLOBULINS-F9839170DD, IVIG (immune globulin IV): Asceniv; Alyglo; Bivigam; Flebogamma; Gamunex-C; Gammagard Liquid; Gammagard S/D; Gammagard Liquid ERC; Gammaked; Gammaplex; Octagam; Privigen; Panzyga; Yimmugo

BCBSIL-RX504.003, Immunoglobulin Therapy

BCBSIL-ADM1001.034, Specialty Medication Administration Site of Care

BCBSMT-RX504.003, Immunoglobulin Therapy

BCBSMT-ADM1001.034, Specialty Medication Administration Site of Care

BCBSNM-RX504.003, Immunoglobulin Therapy

BCBSNM-ADM1001.034, Specialty Medication Administration Site of Care

BCBSOK-RX504.003, Immunoglobulin Therapy

Have a follow-up question?

Ask Backwork about documentation requirements, denial risks, or coverage in your state.

Ask Backwork about J1576 Sign up free

J1576, Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g.,

HCPCS/CPT

Prior Authorization

Prior Auth Required

At least one active policy explicitly requires prior authorization (high confidence)

Medicare Pricing

Work RVU

0.00

Facility

N/A

Non-Facility

N/A

Documentation Required

Claims missing required NOC narrative information or with incorrect unit reporting will be rejected as unprocessable and may show remark code M123.
All documentation must be maintained in the patient's medical record, be legible, include complete patient identification and dates of service, and be produced upon contractor request.
Medical records must include the legible signature of the physician or non-physician practitioner responsible for the care.
The submitted medical record must support the ICD-10-CM code(s), the CPT/HCPCS code(s) billed, and the medical necessity of services as stated in the applicable NCD and LCD.
Records should include relevant diagnostic laboratory studies, prior history of bleeding or infection, disease progression, prior medical/surgical therapies, vaccination response, and any other information essential to establish that the patient meets NCD/LCD coverage indications.
Accurate patient weight in kilograms must be documented prior to infusion because immune globulin dosing is mg/kg based.

Key Coverage Criteria

Billing and coding guidance in this article applies when immune globulin use meets the reasonable and necessary coverage criteria established in LCD L35093.
Coverage requires documentation that the immune globulin therapy is reasonable and necessary in accordance with LCD L34007 and applicable NCDs.
Off-label IVIG use may be billed when supported by the applicable Local Coverage Determination (LCD) and by documentation of medical necessity; off-label is defined as not in Medicare-approved compendia or the FDA label.
IVIG may be used in bone marrow/stem cell transplantation when the recipient was CMV seropositive before transplantation, or after allogeneic transplantation for hematologic neoplasm when both donor and recipient were CMV seronegative.
IVIG may be used in solid organ transplantation when the donor was CMV seropositive and the recipient was CMV seronegative prior to transplantation.
IVIG may be used for recurrent severe infections when there is documented severe or absent IgG subclass deficiency or clinically significant functional humoral immunity deficiency (failure to produce specific antibodies) with a history of recurrent infections.

20 Active Policies

NGS-J6-L39314, Off-Label Use of Intravenous Immune Globulin (IVIG)

A59105, Billing and Coding: Off-Label Use of Intravenous Immune Globulin (IVIG)

FIRST_COAST-L34007, Immune Globulin

A57778, Billing and Coding: Immune Globulin

NORIDIAN-JE-L34314, Immune Globulin Intravenous (IVIg)

NORIDIAN-JF-L34314, Immune Globulin Intravenous (IVIg)

NOVITAS-JH-L35093, Immune Globulin

PALMETTO-JJ-L34580, Intravenous Immunoglobulin (IVIG)

NGS-JK-L39314, Off-Label Use of Intravenous Immune Globulin (IVIG)

A56786, Billing and Coding: Immune Globulin

NOVITAS-JL-L35093, Immune Globulin

PALMETTO-JM-L34580, Intravenous Immunoglobulin(IVIG)

BCBSIL-RX504.003, Immunoglobulin Therapy

BCBSIL-ADM1001.034, Specialty Medication Administration Site of Care

BCBSMT-RX504.003, Immunoglobulin Therapy

BCBSMT-ADM1001.034, Specialty Medication Administration Site of Care

BCBSNM-RX504.003, Immunoglobulin Therapy

BCBSNM-ADM1001.034, Specialty Medication Administration Site of Care

BCBSOK-RX504.003, Immunoglobulin Therapy

Have a follow-up question?

Ask Backwork about documentation requirements, denial risks, or coverage in your state.

Ask Backwork about J1576 Sign up free

`J1576`, Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g.,

Prior Authorization

Medicare Pricing

Documentation Required

Key Coverage Criteria

20 Active Policies

Related Codes

Have a follow-up question?

`J1576`, Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g.,

Prior Authorization

Medicare Pricing

Documentation Required

Key Coverage Criteria

20 Active Policies

Related Codes

Have a follow-up question?

J1576, Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g.,

Prior Authorization

Medicare Pricing

Documentation Required

Key Coverage Criteria

20 Active Policies

Related Codes

Have a follow-up question?

J1576, Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g.,

Prior Authorization

Medicare Pricing

Documentation Required

Key Coverage Criteria

20 Active Policies

Related Codes

Have a follow-up question?

`J1576`, Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g.,

`J1576`, Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g.,